Literature DB >> 21116777

Inhibitory activities of anthraquinones from Rubia akane on phosphatase regenerating liver-3.

Mi Kyeong Moon1, Young-Min Han, Yu-Jin Lee, Lan Hee Lee, Jae Heon Yang, Byoung-Mog Kwon, Dae Keun Kim.   

Abstract

The methanolic extract of the roots of Rubia akane (Rubiaceae) was found to show inhibitory activity on phosphatase of regenerating liver-3 (PRL-3). Bioassay-guided fractionation of the methanolic extract resulted in the isolation of two anthraquinone compounds, 2-methyl-1,3,6-trihydroxy-9,10-anthraquinone-3-O-(6'-O-acetyl)-α-rhamnosyl(1→2)-β-glucoside and 2-methyl-1,3,6-trihydroxy-9,10-anthraquinone, as inhibitors on PRL-3. These compounds inhibited PRL-3 in a dose-dependent manner with IC₅₀ values of 5.2 and 1.3 μg/mL, respectively.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21116777     DOI: 10.1007/s12272-010-1106-4

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  4 in total

1.  Biochemical evaluation of virtual screening methods reveals a cell-active inhibitor of the cancer-promoting phosphatases of regenerating liver.

Authors:  Birgit Hoeger; Maren Diether; Pedro J Ballester; Maja Köhn
Journal:  Eur J Med Chem       Date:  2014-08-20       Impact factor: 6.514

Review 2.  Targeting phosphatases of regenerating liver (PRLs) in cancer.

Authors:  Min Wei; Konstantin V Korotkov; Jessica S Blackburn
Journal:  Pharmacol Ther       Date:  2018-06-05       Impact factor: 12.310

Review 3.  Chemical diversity, medicinal potentialities, biosynthesis, and pharmacokinetics of anthraquinones and their congeners derived from marine fungi: a comprehensive update.

Authors:  Mohamed Sebak; Fatma Molham; Claudio Greco; Mohamed A Tammam; Mansour Sobeh; Amr El-Demerdash
Journal:  RSC Adv       Date:  2022-09-01       Impact factor: 4.036

4.  Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer.

Authors:  Sigve Andersen; Elin Richardsen; Mehrdad Rakaee; Helena Bertilsson; Roy Bremnes; Magne Børset; Lill-Tove Busund; Tobias Slørdahl
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.